 SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 GLOBE NEWSWIRE -- CytomX Therapeutics, Inc. Nasdaq: CTMX, a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody technology platform, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on January 14th at 11:40 a.m. ET. 